Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021–2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively

Trial Identifier: GRC00102
Sponsor: Sanofi Pasteur, a Sanofi Company
Start Date: September 2021
Primary Completion Date: November 2021
Study Completion Date: November 2021
Condition: Influenza Immunisation; Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
United States, Kentucky BARDSTOWN, Kentucky, United States, 40004
United States, Utah Salt Lake City, Utah, United States, 84121